Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam vs diclofenac for postoperative pain after inguinal hernia repair
IRCT20221126056613N7Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative pain comparing Meloxicam with Diclofenac (2 arms). Primary endpoints: Postoperative pain intensity and Adverse effects of meloxicam vs diclofenac. Started May 2024; status: completed.
02
Drugs
meloxicamdiclofenac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20221126056613N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221126056613N7.